Statements Author contributions AH: Conceptualization, Writing original draft, Writing review & editing
They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
Remo treatment showed a dose-dependent improvement, with the 25-mg/kg dose reducing both markers by approximately 52.5%
Because injections and IV therapy bypass your digestive tract, these powerful antioxidants quickly travel to cells throughout your body, going right to work to fight free radicals and support your metabolism
Antihistamines or creams may ease the symptoms